
Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
The Best Portable Applications for Emotional wellness and Prosperity - 2
The most effective method to Pick the Best Wellbeing Highlights for Seniors in SUVs - 3
'Wuthering Heights' trailer features Margot Robbie and Jacob Elordi in a steamy forbidden romance - 4
NASA counts down for first crewed lunar mission in half a century - 5
Apollo vs. Artemis: What to know about NASA's return to the moon
Former 'Bachelorette' welcomes 1st baby via emergency c-section
My Excursion to a Better Way of life: Health Experiences
Remote Headphones: Upgrade Your Sound Insight
Gen Z workplace stereotypes were TV’s favorite punchline in 2025
6 Hints to Upgrade Your Appeal, In addition to Your Outlook
The Secret Side of Italy: 12 Underrated Destinations Locals Don’t Want Tourists to Find
From Educational Loans to Obligation Free: Independence from the rat race Accomplished
Collection of 7,000-year-old ostrich eggs discovered under sand dunes in southern Israel
Weight-loss pill approval set to accelerate food industry product overhauls












